RESUMEN
Agonist-induced phosphorylation is a crucial step in the activation/deactivation cycle of G protein-coupled receptors (GPCRs), but direct determination of individual phosphorylation events has remained a major challenge. We have recently developed a bead-based immunoassay for the quantitative assessment of agonist-induced GPCR phosphorylation that can be performed entirely in 96-well plates, thus eliminating the need for western blot analysis. In the present study, we adapted this assay to three novel phosphosite-specific antibodies directed against the neurokinin 1 (NK1) receptor, namely pS338/pT339-NK1, pT344/pS347-NK1, and pT356/pT357-NK1. We found that substance P (SP) stimulated concentration-dependent phosphorylation of all three sites, which could be completely blocked in the presence of the NK1 receptor antagonist aprepitant. The other two endogenous ligands of the tachykinin family, neurokinin A (NKA) and neurokinin B (NKB), were also able to induce NK1 receptor phosphorylation, but to a much lesser extent than substance P. Interestingly, substance P promoted phosphorylation of the two distal sites more efficiently than that of the proximal site. The proximal site was identified as a substrate for phosphorylation by protein kinase C. Analysis of GPCR kinase (GRK)-knockout cells revealed that phosphorylation was mediated by all four GRK isoforms to similar extents at the T344/S347 and the T356/T357 cluster. Knockout of all GRKs resulted in abolition of all phosphorylation signals highlighting the importance of these kinases in agonist-mediated receptor phosphorylation. Thus, the 7TM phosphorylation assay technology allows for rapid and detailed analyses of GPCR phosphorylation.
Asunto(s)
Receptores de Neuroquinina-1 , Sustancia P , Receptores de Neuroquinina-1/metabolismo , Receptores de Neuroquinina-1/agonistas , Fosforilación/efectos de los fármacos , Humanos , Sustancia P/farmacología , Animales , Inmunoensayo/métodos , Cricetulus , Células CHO , Ratones , Antagonistas del Receptor de Neuroquinina-1/farmacología , Neuroquinina A/farmacología , Neuroquinina A/metabolismoRESUMEN
Con el fin de inducir algunas de las alteraciones que ocurren durante los ataques de migraña, hemos estimulado eléctricamente y unflateralmente el ganglio del trigémino de la rata, durante 5-30 minutos, para conocer en el núcleo caudal del trigémino las modifícaciones que aparecen en la distribución de los neuropéptidos sustancia P, neuroquinina A y péptido relacionado con el gen de la calcitonina. Una vez realizada la estimulación y la técnica inmunocitoquímica, observamos en secciones seriadas del núcleo caudal del trigémino ipsilateral una disminución signifícativa, con respecto al lado contralateral, de las terminaciones nerviosas inmunorreactivas que contienen a los neuropéptidos mencionados. Estas observaciones indican que durante los ataques de migraña, los tres neuropéptidos se liberan conjuntamente en el núcleo caudal del trigémino en donde actuarían a nivel de la primera sinapsis de la vía sensorial trigeminal como neurotransmisores y/o neuromoduladores de la información nociceptiva. (AU)